History
  • No items yet
midpage
Jazz Pharm., Inc. v. Synchrony Grp., LLC
343 F. Supp. 3d 434
E.D. Pa.
2018
Read the full case

Background

  • Jazz Pharmaceuticals hired Synchrony under a Master Services Agreement (MSA) (2012, amended through Mar. 1, 2018) to provide marketing services for Xyrem and other sleep drugs; the MSA contained confidentiality and return/destroy provisions for Jazz’s proprietary information.
  • Jazz provided Synchrony with nonpublic marketing strategies, sales and prescriber data, market research, comparative analyses, and REMS-related research; Jazz alleges it took steps to safeguard these materials.
  • In late 2017 Synchrony told Jazz it would provide services to Harmony (a competitor with a narcolepsy drug) and moved personnel to that account; Synchrony’s CEO admitted disclosing several Jazz employee names to Harmony and some Jazz materials were not returned immediately.
  • Jazz sued alleging violations of the DTSA, PUTSA, breach of contract (California law), breach of duty of loyalty, and breach of fiduciary duty (Pennsylvania law), and sought injunctive relief; a stipulated preliminary injunction was entered requiring return of listed confidential information and an end to use/disclosure pending resolution.
  • Synchrony moved to dismiss for lack of subject-matter jurisdiction (mootness) and for failure to state claims; the court considered jurisdiction/mootness first and then merits under Rule 12(b)(6).

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Mootness of injunctive relief Jazz contends injunction not fully complied with and seeks permanent injunction too Synchrony says compliance with stipulated preliminary injunction moots injunctive claim Court: Injunctive claim not moot — disputes remain about compliance and permanent relief still sought
Breach of contract (MSA) Jazz says Synchrony used/disclosed confidential info, failed to return/destroy materials, and breached due-care obligations Synchrony contends Jazz did not plead a contractual breach Court: Jazz plausibly alleged breaches of MSA (use/disclosure, failure to return/destroy, breach of due-care) — Count III survives
Misappropriation under DTSA/PUTSA Jazz alleges actual and threatened misappropriation based on access, sharing with Harmony, and staffing overlap Synchrony says allegations are speculative and concern only awareness, not misuse; employee names not trade secrets Court: Jazz adequately pleaded trade secrets (excluding employee names) and alleged facts supporting actual and threatened misappropriation — Counts I and II survive
Breach of fiduciary duty / duty of loyalty Jazz claims high trust created fiduciary duties beyond contract Synchrony says no special relationship; gist of the action doctrine bars tort claims grounded in the contract Court: Gist of the action doctrine bars Counts IV and V because duties alleged arise from the MSA; those counts dismissed

Key Cases Cited

  • Bell Atl. Corp. v. Twombly, 550 U.S. 544 (2007) (pleading must state a plausible claim)
  • ALA, Inc. v. CCAIR, Inc., 29 F.3d 855 (3d Cir. 1994) (standards for evaluating Rule 12(b)(6) motions)
  • Old Bridge Owners Coop. Corp. v. Twp. of Old Bridge, 246 F.3d 310 (3d Cir. 2001) (mootness principles)
  • Knox v. Serv. Emps., 567 U.S. 298 (2012) (Article III standing/mootness discussion)
  • Bimbo Bakeries USA, Inc. v. Botticella, 613 F.3d 102 (3d Cir. 2010) (trade secret/inevitable disclosure principles)
  • Bohler-Uddeholm Am., Inc. v. Ellwood Group, Inc., 247 F.3d 79 (3d Cir. 2001) (when breach of fiduciary duty can reflect broader social policy beyond contract)
Read the full case

Case Details

Case Name: Jazz Pharm., Inc. v. Synchrony Grp., LLC
Court Name: District Court, E.D. Pennsylvania
Date Published: Dec 3, 2018
Citation: 343 F. Supp. 3d 434
Docket Number: CIVIL ACTION NO. 18-602
Court Abbreviation: E.D. Pa.